- Home
- KMDA vs NLOP Comparison
KMDA vs NLOP Comparison
Compare KMDA & NLOP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KMDA
- NLOP
- Stock Information
- Founded
- KMDA 1990
- NLOP N/A
- Country
- KMDA Israel
- NLOP United States
- Employees
- KMDA N/A
- NLOP N/A
- Industry
- KMDA Biotechnology: Pharmaceutical Preparations
- NLOP
- Sector
- KMDA Health Care
- NLOP
- Exchange
- KMDA Nasdaq
- NLOP Nasdaq
- Market Cap
- KMDA 430.1M
- NLOP 498.8M
- IPO Year
- KMDA N/A
- NLOP N/A
- Fundamental
- Price
- KMDA $7.35
- NLOP $33.12
- Analyst Decision
- KMDA Strong Buy
- NLOP Strong Buy
- Analyst Count
- KMDA 2
- NLOP 1
- Target Price
- KMDA $13.00
- NLOP $46.00
- AVG Volume (30 Days)
- KMDA 49.4K
- NLOP 104.6K
- Earning Date
- KMDA 08-13-2025
- NLOP 01-01-0001
- Dividend Yield
- KMDA 2.72%
- NLOP 1.03%
- EPS Growth
- KMDA 27.97
- NLOP N/A
- EPS
- KMDA 0.32
- NLOP N/A
- Revenue
- KMDA $169,517,000.00
- NLOP $117,598,000.00
- Revenue This Year
- KMDA $14.51
- NLOP N/A
- Revenue Next Year
- KMDA $9.31
- NLOP N/A
- P/E Ratio
- KMDA $22.26
- NLOP N/A
- Revenue Growth
- KMDA 9.67
- NLOP N/A
- 52 Week Low
- KMDA $5.17
- NLOP $26.10
- 52 Week High
- KMDA $9.16
- NLOP $34.53
- Technical
- Relative Strength Index (RSI)
- KMDA 48.99
- NLOP 49.56
- Support Level
- KMDA $7.15
- NLOP $32.45
- Resistance Level
- KMDA $7.85
- NLOP $34.24
- Average True Range (ATR)
- KMDA 0.22
- NLOP 0.75
- MACD
- KMDA 0.00
- NLOP -0.06
- Stochastic Oscillator
- KMDA 54.13
- NLOP 36.01
About KMDA Kamada Ltd.
Kamada Ltd is a drug-focused, plasma-derived protein therapeutics company. It is involved in the business of developing, producing, and marketing specialty therapeutics using protein purification proprietary technology. Its product portfolio consists of Glassia, Bramitob, Foster, Ixiaro, Factor-IX, and others. The company has two segments namely, the Proprietary Products segment and the Distribution segment. It derives the majority of its revenue from the Proprietary products segment. The firm categorizes its products in Lung Disease, Vaccines, Haemophilia, Immunoglobulins, Critical care, and Diagnostics.
About NLOP Net Lease Office Properties of Beneficial Interest
Net Lease Office Properties is a Maryland real estate investment trust that, together with its consolidated subsidiaries, owns a diversified portfolio of office properties that are primarily leased to corporate tenants on a single-tenant, net-lease basis. Its net leases generally specify a base rent with rent increases and require the tenant to pay substantially all costs associated with operating and maintaining the property. Its portfolio includes approximately 1.2 million square feet of Green-Certified Buildings, 2 LEED-certified buildings, and 1 BREEAM-certified building.